Visualize Change LLC is a licensed substance use treatment provider in Ashland, PA, listed in the SAMHSA treatment directory. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-payment
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agency
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
11 Anthra Plaza, 148 State Route 2026, Coal Township, PA 17866
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid
1 South 2nd Street, 4th Floor, Pottsville, PA 17901
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid
1 South 2nd Street, 1st Floor, Pottsville, PA 17901
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid